OTCPK:SMLR

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

Semler Scientific, Inc. develops, manufactures, and markets proprietary products that assist healthcare providers to evaluate and treat patients with chronic diseases in the United States. More Details


Snowflake Analysis

Flawless balance sheet with solid track record.

Share Price & News

How has Semler Scientific's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: SMLR has not had significant price volatility in the past 3 months.


Market Performance


7 Day Return

7.8%

SMLR

1.5%

US Medical Equipment

1.8%

US Market


1 Year Return

27.9%

SMLR

16.2%

US Medical Equipment

14.2%

US Market

Return vs Industry: SMLR exceeded the US Medical Equipment industry which returned 16.2% over the past year.

Return vs Market: SMLR exceeded the US Market which returned 14.2% over the past year.


Shareholder returns

SMLRIndustryMarket
7 Day7.8%1.5%1.8%
30 Day0%1.2%0.04%
90 Day17.6%12.3%9.8%
1 Year27.9%27.9%17.2%16.2%16.7%14.2%
3 Year1,258.0%1,258.0%75.0%70.4%41.6%32.2%
5 Year2,015.4%2,015.4%144.8%126.4%90.9%69.5%

Price Volatility Vs. Market

How volatile is Semler Scientific's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Semler Scientific undervalued compared to its fair value and its price relative to the market?

39.9%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: SMLR ($55) is trading below our estimate of fair value ($91.44)

Significantly Below Fair Value: SMLR is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: SMLR is good value based on its PE Ratio (25x) compared to the US Medical Equipment industry average (48.4x).

PE vs Market: SMLR is poor value based on its PE Ratio (25x) compared to the US market (18.6x).


Price to Earnings Growth Ratio

PEG Ratio: SMLR is good value based on its PEG Ratio (0.8x)


Price to Book Ratio

PB vs Industry: SMLR is overvalued based on its PB Ratio (21.2x) compared to the US Medical Equipment industry average (4x).


Next Steps

Future Growth

How is Semler Scientific forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?

30.9%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: SMLR's forecast earnings growth (30.9% per year) is above the savings rate (2.2%).

Earnings vs Market: SMLR's earnings (30.9% per year) are forecast to grow faster than the US market (23.3% per year).

High Growth Earnings: earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: SMLR's revenue (42.5% per year) is forecast to grow faster than the US market (9.7% per year).

High Growth Revenue: SMLR's revenue (42.5% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if SMLR's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has Semler Scientific performed over the past 5 years?

75.6%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: SMLR has a high level of non-cash earnings.

Growing Profit Margin: SMLR's current net profit margins (42.4%) are higher than last year (28.1%).


Past Earnings Growth Analysis

Earnings Trend: SMLR has become profitable over the past 5 years, growing earnings by 75.6% per year.

Accelerating Growth: SMLR's earnings growth over the past year (94.2%) exceeds its 5-year average (75.6% per year).

Earnings vs Industry: SMLR earnings growth over the past year (94.2%) exceeded the Medical Equipment industry -0.2%.


Return on Equity

High ROE: SMLR's Return on Equity (84.4%) is considered outstanding.


Next Steps

Financial Health

How is Semler Scientific's financial position?


Financial Position Analysis

Short Term Liabilities: SMLR's short term assets ($15.3M) exceed its short term liabilities ($4.4M).

Long Term Liabilities: SMLR has no long term liabilities.


Debt to Equity History and Analysis

Debt Level: SMLR is debt free.

Reducing Debt: SMLR has no debt compared to 5 years ago when its debt to equity ratio was 117%.

Debt Coverage: SMLR has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: SMLR has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Next Steps

Dividend

What is Semler Scientific current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate SMLR's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate SMLR's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if SMLR's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if SMLR's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of SMLR's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

7.7yrs

Average management tenure


CEO

Doug Murphy-Chutorian (66 yo)

7.92yrs

Tenure

US$1,170,253

Compensation

Dr. Douglas Murphy-Chutorian, also known as Doug, M.D. has been the Chief Executive Officer of Semler Scientific, Inc since October 31, 2012 and served as its President. Dr. Murphy-Chutorian serves as Corp ...


CEO Compensation Analysis

Compensation vs Market: Doug's total compensation ($USD1.17M) is below average for companies of similar size in the US market ($USD2.02M).

Compensation vs Earnings: Doug's compensation has been consistent with company performance over the past year.


Leadership Team

NamePositionTenureCompensationOwnership
Douglas Murphy-Chutorian
CEO, Corporate Secretary & Director7.92yrsUS$1.17m0.97%
$ 3.5m
Andrew Weinstein
Senior Vice President of Finance & Accounting1.92yrsUS$322.31k0%
$ 0
Herbert Semler
Founder & Chairman Emeritusno dataUS$47.84kno data
Robert McRae
Chief Technical Officerno dataUS$256.96kno data
Dennis Rosenberg
Chief Marketing Officer7.67yrsno datano data

7.7yrs

Average Tenure

66yo

Average Age

Experienced Management: SMLR's management team is seasoned and experienced (7.7 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Douglas Murphy-Chutorian
CEO, Corporate Secretary & Director7.92yrsUS$1.17m0.97%
$ 3.5m
Herbert Semler
Founder & Chairman Emeritusno dataUS$47.84kno data
Daniel Messina
Independent Director0.083yrno data0%
$ 0
Arthur Leibowitz
Independent Director6.25yrsUS$67.50k0%
$ 0
Wayne Pan
Independent Director6.33yrsUS$70.50k0%
$ 0

6.3yrs

Average Tenure

66yo

Average Age

Experienced Board: SMLR's board of directors are considered experienced (6.3 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Semler Scientific, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Semler Scientific, Inc.
  • Ticker: SMLR
  • Exchange: OTCPK
  • Founded: 2007
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: US$361.737m
  • Shares outstanding: 6.58m
  • Website: https://www.semlerscientific.com

Number of Employees


Location

  • Semler Scientific, Inc.
  • 911 Bern Court
  • Suite 110
  • San Jose
  • California
  • 95112
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
SMLROTCPK (Pink Sheets LLC)YesCommon SharesUSUSDFeb 2014

Biography

Semler Scientific, Inc. develops, manufactures, and markets proprietary products that assist healthcare providers to evaluate and treat patients with chronic diseases in the United States. Its products inc ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/09/18 06:06
End of Day Share Price2020/09/17 00:00
Earnings2020/06/30
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.